Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BROMOCRIPTINE for Pituitary tumour: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where BROMOCRIPTINE was used for Pituitary tumour.

Most Reported Side Effects for BROMOCRIPTINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 138 16.0% 18 55
Drug intolerance 60 6.9% 0 22
Off label use 58 6.7% 13 25
Neuroleptic malignant syndrome 53 6.1% 16 42
Headache 49 5.7% 3 20
Maternal exposure during pregnancy 45 5.2% 5 21
Foetal exposure during pregnancy 41 4.8% 5 5
Nausea 38 4.4% 2 8
Exposure during pregnancy 32 3.7% 2 17
Malaise 31 3.6% 0 10
Vomiting 30 3.5% 2 8
Serotonin syndrome 28 3.2% 0 13
Somnolence 28 3.2% 1 10
Blood prolactin increased 27 3.1% 0 5
Fall 27 3.1% 0 10

Other Indications for BROMOCRIPTINE

Product used for unknown indication (205) Prolactin-producing pituitary tumour (127) Neuroleptic malignant syndrome (54) Hyperprolactinaemia (43) Pituitary tumour benign (42) Parkinson's disease (33) Foetal exposure during pregnancy (30) Lactation inhibition therapy (29) Acromegaly (19) Blood prolactin increased (16)

Other Drugs Used for Pituitary tumour

OCTREOTIDE (137) SOMATROPIN (121) CABERGOLINE (84) PEGVISOMANT (82) TEMOZOLOMIDE (77) PASIREOTIDE (43) LANREOTIDE (36) BEVACIZUMAB (11) TESTOSTERONE (10) CAPECITABINE (8)

Related Pages

BROMOCRIPTINE Full Profile All Pituitary tumour Drugs BROMOCRIPTINE Demographics BROMOCRIPTINE Timeline